1. DOP11 Normalisation of faecal calprotectin within 12 months of diagnosis is associated with a reduced risk of disease progression in Crohn's disease. (15th January 2020) Authors: Plevris, N; Fulforth, J; Jenkinson, P; Lyons, M; Chuah, C; Siakavellas, S; Pattenden, R; Arnott, I; Jones, G; Lees, C Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗